Synthetic toll-like receptor 4 agonists stimulate innate resistance to infectious challenge

Infection and Immunity

Volumn 73, Issue 5, 2005, Pages 3044-3052

  Cluff, Christopher W ^a   Baldridge, Jory R ^a   Stöver, Axel G ^a   Evans, Jay T ^a   Johnson, David A ^a   Lacy, Michael J ^a   Clawson, Valerie G ^a   Yorgensen, Vonnie M ^a   Johnson, Craig L ^a   Livesay, Mark T ^a   Hershberg, Robert M ^a,b   Persing, David H ^a,b  

^a GLAXOSMITHKLINE   (United States)

^b INFECTIOUS DISEASE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOALKYL GLUCOSAMINIDE PHOSPHATE; FUNCTIONAL GROUP; LIPID A; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CELL STIMULATION; CHEMICAL COMPOSITION; COLONY FORMING UNIT; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG INACTIVATION; DRUG SCREENING; EFFECTOR CELL; INFECTION PREVENTION; INFECTION RESISTANCE; INFLUENZA; INFLUENZA VIRUS; INNATE IMMUNITY; LISTERIA MONOCYTOGENES; LISTERIOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROVOCATION TEST; SIGNAL TRANSDUCTION; SPLEEN; STRUCTURE ACTIVITY RELATION; WILD TYPE;

ANIMALS; FEMALE; IMMUNITY, NATURAL; INFLUENZA A VIRUS; LIPID A; LISTERIA INFECTIONS; LISTERIA MONOCYTOGENES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MOLECULAR MIMICRY; ORTHOMYXOVIRIDAE INFECTIONS; RECEPTORS, CELL SURFACE; STRUCTURE-ACTIVITY RELATIONSHIP; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS;

EID: 20244369887     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.73.5.3044-3052.2005     Document Type: Article

References (45)

1. Akira, S. 2003. Mammalian Toll-like receptors. Curr. Opin. Immunol. 15:5-11.
2. Ayabe, T., D. P. Satchell, C. L. Wilson, W. C. Parks, M. E. Selsted, and A. J. Ouellette. 2000. Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. Nat. Immunol. 1:113-118.
3. Baldridge, J. R., C. W. Cluff, J. T. Evans, M. J. Lacy, J. R. Stephens, V. G. Brookshire, R. Wang, J. R. Ward, Y. M. Yorgensen, D. H. Persing, and D. A. Johnson. 2002. Immunostimulatory activity of aminoalkyl glucosaminide 4-phosphates (AGPs): induction of protective innate immune responses by RC-524 and RC-529. J. Endotoxin Res. 8:453-458.
4. Berger, F. M. 1967. The effect of endotoxin on resistance to infection and disease. Adv. Pharmacol. 5:19-46.
5. Caamano, J., and C. A. Hunter. 2002. NF-kappaB family of transcription factors: central regulators of innate and adaptive immune functions. Clin. Microbiol. Rev. 15:414-429.
6. Evans, J. T., C. W. Cluff, D. A. Johnson, M. J. Lacy, D. H. Persing, and J. R. Baldridge. 2003. Enhancement of antigen-specific immunity via the TLR4 ligands MPL adjuvant and Ribi.529. Expert Rev. Vaccines 2:219-229.
7. Friedland, N., H. L. Liou, P. Lobel, and A. M. Stock. 2003. Structure of a cholesterol-binding protein deficient in Niemann-Pick type C2 disease. Proc. Natl. Acad. Sci. USA 100:2512-2517.
8. Gioannini, T. L., A. Teghanemt, D. Zhang, N. P. Coussens, W. Dockstader, S. Ramaswamy, and J. P. Weiss. 2004. Isolation of an endotoxin-MD-2 complex that produces Toll-like receptor 4-dependent cell activation at picomolar concentrations. Proc. Natl. Acad. Sci. USA 101:4186-4191.
9. Gruber, A., M. Mancek, H. Wagner, and C. J. Kirschning. 2004. Structural model of MD-2 and functional role of its basic amino acid clusters involved in cellular lipopolysaccharide recognition. J. Biol. Chem. 279:28473-28482.
10. Hagberg, L., R. Hull, S. Hull, J. R. McGhee, S. M. Michalek, and C. Svanborg Eden. 1984. Difference in susceptibility to gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice. Infect. Immun. 46:839-844.
11. Hoebe, K., X. Du, P. Georgel, E. Janssen, K. Tabeta, S. O. Kim, J. Goode, P. Lin, N. Mann, S. Mudd, K. Crozat, S. Sovath, J. Han, and B. Beutler. 2003. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 424:743-748.
12. Johnson, A. G. 1994. Molecular adjuvants and immunomodulators: new approaches to immunization. Clin. Microbiol. Rev. 7:277-289.
13. Johnson, D. A., D. S. Keegan, C. G. Sowell, M. T. Livesay, C. L. Johnson, L. M. Taubner, A. Harris, K. R. Myers, J. D. Thompson, G. L. Gustafson, M. J. Rhodes, J. T. Ulrich, J. R. Ward, Y. M. Yorgensen, J. L. Cantrell, and V. G. Brookshire. 1999. 3-O-desacyl monophosphoryl lipid A derivatives: synthesis and immunostimulant activities. J. Med. Chem. 42:4640-4649.
14. Johnson, D. A., C. G. Sowell, C. L. Johnson, M. T. Livesay, D. S. Keegan, M. J. Rhodes, J. T. Ulrich, J. R. Ward, J. L. Cantrell, and V. G. Brookshire. 1999. Synthesis and biological evaluation of a new class of vaccine adjuvants: aminoalkyl glucosaminide 4-phosphates (AGPs). Bioorg. Med. Chem. Lett. 9:2273-2278.
15. Kaisho, T., and S. Akira. 2002. Toll-like receptors as adjuvant receptors. Biochim. Biophys. Acta 1589:1-13.
16. Kawai, T., O. Adachi, T. Ogawa, K. Takeda, and S. Akira. 1999. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11:115-122.
17. Kennedy, M., G. Mullen, C. Leifer, C. Lee, A. Mazzoni, K. Dileepan, and D. Segal. 2004. A complex of soluble MD-2 and lipopolysaccharide serves as an activating ligand for toll-like receptor 4. J. Biol. Chem.
18. Macela, A., J. Stulik, L. Hernychova, M. Kroca, Z. Krocova, and H. Kovarova. 1996. The immune response against Francisella tularensis live vaccine strain in Lps(n) and Lps(d) mice. FEMS Immunol. Med. Microbiol. 13:235-238.
19. Masihi, K. N., W. Lange, W. Brehmer, and E. Ribi. 1986. Immunobiological activities of nontoxic lipid A: enhancement of nonspecific resistance in combination with trehalose dimycolate against viral infection and adjuvant effects. Int. J. Immunopharmacol. 8:339-345.
20. Medzhitov, R., and C. Janeway, Jr. 2000. Innate immune recognition: mechanisms and pathways. Immunol. Rev. 173:89-97.
21. Miyake, K. 2004. Innate recognition of lipopolysaccharide by Toll-like receptor 4-MD-2. Trends Microbiol. 12:186-192.
22. Mullen, G. E. D., M. N. Kennedy, A. Visintin, A. Mazzoni, C. A. Leifer, D. R. Davies, and D. M. Segal. 2003. The role of disulfide bonds in the assembly and function of MD-2. Proc. Natl. Acad. Sci. USA 100:3919-3924.
23. Muller, J. M., H. W. Ziegler-Heitbrock, and P. A. Baeuerle. 1993. Nuclear factor kappa B, a mediator of lipopolysaccharide effects. Immunobiology 187:233-256.
24. Myers, K. R., A. T. Truchot, J. Ward, Y. Hudson, and J. T. Ulrich. 1990. A critical determinant of lipid A endotoxic activity, p. 145-156. In A. Nowotny, J. J. Spitzer, and E. J. Ziegler (ed.), Cellular and molecular aspects of endotoxin reactions. Elsevier Sciences Publishers B.V., Amsterdam, The Netherlands.
25. Neter, E. 1969. Endotoxins and the immune response. Curr. Top. Microbiol. Immunol. 47:82-124.
26. Nikolic-Zugic, J., and F. R. Carbone. 1991. Peptide presentation by class-I major histocompatibility complex molecules. Immunol. Res. 10:54-65.
27. O'Brien, A. D., D. L. Rosenstreich, I. Scher, G. H. Campbell, R. P. MacDermott, and S. B. Formal. 1980. Genetic control of susceptibility to Salmonella typhimurium in mice: role of the LPS gene. J. Immunol. 124:20-24.
28. O'Neill, L. A., A. Dunne, M. Edjeback, P. Gray, C. Jefferies, and C. Wietek. 2003. Mal and MyD88: adapter proteins involved in signal transduction by Toll-like receptors. J. Endotoxin Res. 9:55-59.
29. Persing, D. H., R. N. Coler, M. J. Lacy, D. A. Johnson, J. R. Baldridge, R. M. Hershberg, and S. G. Reed. 2002. Taking toll: lipid A mimetics as adjuvants and immunomodulators. Trends Microbiol. 10:S32-S37.
30. Poltorak, A., X. He, I. Smirnova, M. Y. Liu, C. V. Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, M. Freudenberg, P. Ricciardi-Castagnoli, B. Layton, and B. Beutler. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085-2088.
31. Poltorak, A., I. Smirnova, X. He, M. Y. Liu, C. Van Huffel, O. McNally, D. Birdwell, E. Alejos, M. Silva, X. Du, P. Thompson, E. K. Chan, J. Ledesma, B. Roe, S. Clifton, S. N. Vogel, and B. Beutler. 1998. Genetic and physical mapping of the Lps locus: identification of the toll-4 receptor as a candidate gene in the critical region. Blood Cells Mol. Dis. 24:340-355. (Erratum, 25:78, 1999.)
32. Re, F., and J. L. Strominger. 2003. Seperate functional domains of human MD-2 mediate Toll-like receptor 4-binding and lipopolysaccharide responsiveness. J. Immunol. 171:5272-5276.
33. Rosenstreich, D. L., A. C. Weinblatt, and A. D. O'Brien. 1982. Genetic control of resistance to infection in mice. Crit. Rev. Immunol. 3:263-330.
34. Singh, J., S. S. Sidhu, G. S. Dhaliwal, G. R. Pangaonkar, A. S. Nanda, and A. S. Grewal. 2000. Effectiveness of lipopolysaccharide as an intrauterine immunomodulator in curing bacterial endometritis in repeat breeding crossbred cows. Anim. Reprod. Sci. 59:159-166.
35. Stover, A. G., J. Da Silva Correia, J. T. Evans, C. W. Cluff, M. W. Elliott, E. W. Jeffery, D. A. Johnson, M. J. Lacy, J. R. Baldridge, P. Probst, R. J. Ulevitch, D. H. Persing, and R. M. Hershberg. 2003. Structure-activity relationship of synthetic toll-like receptor 4 agonists. J. Biol. Chem.
36. Sweet, M. J., and D. A. Hume. 1996. Endotoxin signal transduction in macrophages. J. Leukoc. Biol. 60:8-26.
37. Toshchakov, V., B. W. Jones, P. Y. Perera, K. Thomas, M. J. Cody, S. Zhang, B. R. Williams, J. Major, T. A. Hamilton, M. J. Fenton, and S. N. Vogel. 2002. TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages. Nat. Immunol. 3:392-398.
38. Triantafilou, M., K. Miyake, D. T. Golenbock, and K. Triantafilou. 2002. Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. J. Cell Sci. 115:2603-2611.
39. Ulrich, J. M., K. N. Masihi, W. Lange. 1988. Mechanisms of nonspecific resistance to microbial infections induced by trehalose dimycolate (TDM) and monophosphoryl lipid A (MPL), p. 167-178. In K. N. Masihi and W. Lange (ed.), Advances in the biosciences, vol. 68. Pergamon Journals Ltd., Oxford. United Kingdom.
40. Visintin, A., E. Latz, B. G. Monks, T. Espevik, and D. T. Golenbock. 2003. Lysines 128 and 132 enable lipopolysaccharide binding to MD-2, leading to Toll-like receptor-4 aggregation and signal transduction. J. Biol. Chem. 278:48313-48320.
41. Visintin, A., A. Mazzoni, J. A. Spitzer, and D. M. Segal. 2001. Secreted MD-2 is a large polymeric protein that efficiently confers lipopolysaccharide sensitivity to Toll-like receptor 4. Proc. Natl. Acad. Sci. USA 98:12156-12161.
42. Woods, J. P., J. A. Frelinger, G. Warrack, and J. G. Cannon. 1988. Mouse genetic locus Lps influences susceptibility to Neisseria meningitidis infection. Infect. Immun. 56:1950-1955.
43. Wright, C. S., S. C. Li, and F. Rastinejad. 2000. Crystal structure of human GM2-activator protein with a novel beta-cup topology. J. Mol. Biol. 304:411-422.
44. Wright, C. S., Q. Zhao, and F. Rastinejad. 2003. Structural analysis of lipid complexes of GM2-activator protein. J. Mol. Biol. 331:951-964.
45. Yamamoto, M., S. Sato, H. Hemmi, K. Hoshino, T. Kaisho, H. Sanjo, O. Takeuchi, M. Sugiyama, M. Okabe, K. Takeda, and S. Akira. 2003. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301:640-643.